Genesis Capital is an independent investment and merchant banking firm focused on key growth sectors of the economy. We work with public and private corporations as well as family owned businesses to achieve their strategic growth initiatives and maximize shareowner value.
Genesis Capital provides tailored solutions to meet the specific objectives of our clients. Our areas of expertise include mergers, acquisitions, divestitures, leveraged buyouts, going private transactions, private placements of equity and debt, and certain derivative hedging transactions.
Genesis Capital provides tailored solutions to meet the specific objectives of our clients. Our areas of expertise include mergers, acquisitions, divestitures, leveraged buyouts, going private transactions, private placements of equity and debt, and certain derivative hedging transactions.
Location: United States, Georgia, Atlanta
Employees: 11-50
Founded date: 2002
Mentions in press and media 6
| Date | Title | Description |
| 11.07.2026 | Tripo AI raises $150M in Series A3 round | 3D foundation model developer Tripo AI has closed a $150 million Series A3 funding round, drawing investment from companies across the automotive, gaming, internet, and technology sectors. Geely Capital was among the automotive-side backers... |
| 08.07.2026 | Tripo AI Secures $150M for AI 3D, World Model Dominance | Tripo AI secured $150 million in Series A3 funding. This significant capital fuels its advanced 3D foundation and world model development. A diverse investor group, from automotive to gaming, participated. Tripo AI aims to democratize 3D co... |
| 02.07.2026 | Tripo AI Raises Over $150 Million In Series A3 Financing | (See Pulse 2.0 profile here) Tripo AI announced that it has completed a Series A3 financing round, raising over $150 million. The funding round included participation from a broad group of strategic and financial investors spanning the auto... |
| 23.02.2024 | Reprieve Cardiovascular Revolutionizes Heart Failure Treatment with $42M Funding | Reprieve Cardiovascular, a Milford, MA-based company, secures $42M in Series A funding to advance intelligent fluid management for heart failure patients. Led by Lightstone Ventures and Sante Ventures, the funding will propel Reprieve's mis... |
| 22.02.2024 | Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure | What You Should Know: – Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round. – The Series A round was co-led b... |
| 28.03.2019 | A crypto manager lays out the market improvements to the currency and says 2019 will be a year to watch | Getty We can expect a lot of crypto-infrastructure-building activity in 2019. Advertisement In this op-ed, Kyle Samani, a co-founder and managing partner at Multicoin Capital, says that although crypto markets underperformed in 2018, the pa... |